Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DF0DN4
|
|||
| Drug Name |
EDP-788
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Bacterial infection [ICD-11: 1A00-1C4Z; ICD-10: A00-B99] | Phase 1 | [1] | |
| Company |
Enanta Pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02255968) Evaluation of the Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of EDP-788. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.